Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
M Kou, Y Jiao, Z Li, B Wei, Y Li, Y Cai… - European journal of clinical …, 2024 - Springer
Background and objective Multiple randomized controlled studies have shown that
pirfenidone and nintedanib are effective and safe for treating idiopathic pulmonary fibrosis …
pirfenidone and nintedanib are effective and safe for treating idiopathic pulmonary fibrosis …
Neighborhood Disparities in Interstitial Lung Disease: How Do We Capture the Most Vulnerable?
GC Goobie - Annals of the American Thoracic Society, 2024 - atsjournals.org
Neighborhood disadvantage is an important predictor of clinical outcomes in patients with
fibrotic interstitial lung disease (fILD)(1, 2), but until now, we have not known the …
fibrotic interstitial lung disease (fILD)(1, 2), but until now, we have not known the …
Uptake of Antifibrotics for Patients with Idiopathic Pulmonary Fibrosis: 2016–2022
DA Shankar, F Hawkins, KD Alysandratos… - Annals of the …, 2024 - atsjournals.org
Methods We used the TriNetX Analytics Platform Research Network (https://trinetx. com/), an
electronic health record and claims database with inpatient and outpatient data on all …
electronic health record and claims database with inpatient and outpatient data on all …
[PDF][PDF] Recommendations from The Medical Education Editor
M Lavercombe - Respirology, 2022 - minerva-access.unimelb.edu.au
Identification of comorbidities in patients with COPD is vital for several reasons. First,
comorbid conditions such as anxiety and depression, coronary artery disease and …
comorbid conditions such as anxiety and depression, coronary artery disease and …
Missing out on effective care in idiopathic pulmonary fibrosis: Racial inequality in access to anti‐fibrotic therapy.
A Pascoe, N Smallwood - Respirology, 2023 - search.ebscohost.com
The impacts of racial and ethnic disparities on the development, progression and treatment
of many chronic respiratory diseases are being increasingly documented. 1–4 These …
of many chronic respiratory diseases are being increasingly documented. 1–4 These …
Hermansky-Pudlak Syndrome in the United States
A Engel, R Summer, J Roman - Chest, 2025 - pubmed.ncbi.nlm.nih.gov
Hermansky-Pudlak Syndrome in the United States Hermansky-Pudlak Syndrome in the United
States Chest. 2025 Jan 30:S0012-3692(25)00135-7. doi: 10.1016/j.chest.2025.01.022. Online …
States Chest. 2025 Jan 30:S0012-3692(25)00135-7. doi: 10.1016/j.chest.2025.01.022. Online …
Racial gaps in respiratory effects: The influence of personal and community determinants
V Gambhir, VA Bhat, M Abrol, P Nirala - Multidisciplinary Science …, 2024 - malque.pub
In several conditions, such as chronic obstructive pulmonary disease (COPD), the health
results for black individuals are poorer than white adults. To assess the potential contribution …
results for black individuals are poorer than white adults. To assess the potential contribution …